| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af5978c465dc99fa57524ae217ad798f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
2016-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa11cc48f2a800f2325717c15bd93d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b164db9be9ffa1ea61cd0bd0e6a8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af634a86a29cf36cc83994f94526839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d876a080d7242c266988518751c62a07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3c94ba5d3ad6ff4e82f175ac6093867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07a00972d499ed4c0a569036744a8cc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d7c6b88d22f657d2e4d2d9026c2c90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161b474d0b027779e70ede3e7b6cd110 |
| publicationDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10982285-B2 |
| titleOfInvention |
Biomarkers for the identification of prostate cancer and methods of use |
| abstract |
The present disclosure provides biomarkers for the identification of prostate cancer and methods of use. The present disclosure also provide biomarkers that can be used for determining risk of developing prostate cancer, aggressiveness of prostate cancer and survival rate for subpopulations of African American males or non-Hispanic white males. |
| priorityDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |